Medication-related pharmacological manipulations of nicotine self-administration in the rat maintained on fixed- and progressive-ratio schedules of reinforcement.
BACKGROUND
The use of animal models to study existing medications for smoking cessation can elucidate the mechanism(s) of action of cessation agents and further validate the models for medication development.


OBJECTIVE
The objective of the study was to evaluate the response of nicotine self-administration (NSA) to pharmacological agents related to the smoking cessation medication bupropion and to nicotine dosing mimicking nicotine replacement on fixed-ratio (FR) and progressive-ratio (PR) schedules of reinforcement.


METHODS
NSA was maintained at a nicotine dose of 30 microg/kg/infusion i.v. in rats trained on FR5 and PR40% schedules. Pharmacological manipulations related to bupropion were examined by treating animals with a dopamine reuptake inhibitor [GBR 12909 (GBR)], a norepinephrine reuptake inhibitor [nisoxetine (NIS)], and a nicotinic antagonist [dihydro-beta-erythroidine (DHbetaE)]. The effect of nicotine replacement was examined on the PR schedule by chronic dosing with osmotic minipumps.


RESULTS
Significant treatment effects occurred with NIS and combinations of NIS-DHbetaE and with GBR on response rates. Chronic nicotine dosing reduced self-administration. The two schedules yielded different results with some treatments.


CONCLUSIONS
Noradrenergic-nicotinic cholinergic interactions and enhanced responding consequent to dopamine reuptake inhibition may be part of the complex behavioral pharmacology of bupropion-like compounds. Observation of differential results with the two schedules has implication for the use of self-administration techniques to elaborate the mechanisms of dependence as well as drug discovery.
Coen
Kathleen M
KM
Smoking and Nicotine Dependence Research Unit, Department of Neuroscience, Centre for Addiction & Mental Health, Toronto, ON, M5S 2S1, Canada.
Adamson
K Laurel
KL
Corrigall
William A
WA
D000818:Animals; D016642:Bupropion / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology*; D004334:Drug Administration Schedule; D007262:Infusions, Intravenous; D008297:Male; D009538:Nicotine / Q000008:administration & dosage*; D018722:Nicotinic Agonists / Q000008:administration & dosage*; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D020318:Rats, Long-Evans; D011978:Receptors, Nicotinic / Q000187:drug effects / Q000378:metabolism; D012055:Reinforcement Schedule; D012646:Self Administration; D016540:Smoking Cessation
D018765:Dopamine Uptake Inhibitors; D018722:Nicotinic Agonists; D011978:Receptors, Nicotinic; D016642:Bupropion; D009538:Nicotine; D004298:Dopamine; D009638:Norepinephrine
Psychopharmacology (Berl). 2002 Mar;160(3):263-70
11889495
Synapse. 2003 Oct;50(1):20-8
12872290
Psychopharmacology (Berl). 2004 Apr;173(1-2):64-72
14712336
Psychopharmacology (Berl). 2007 Feb;190(3):353-62
16847680
Pharmacol Biochem Behav. 1995 Aug;51(4):687-92
7675844
Pharmacol Biochem Behav. 2002 May;72(1-2):279-89
11900798
Psychopharmacology (Berl). 2003 Feb;165(4):405-12
12451438
J Pharmacol Exp Ther. 2000 Mar;292(3):1053-64
10688623
Pharmacol Biochem Behav. 1981 Apr;14(4):573-4
7232478
Psychopharmacology (Berl). 2001 Nov;158(2):190-7
11702093
Psychopharmacology (Berl). 2004 Mar;172(2):179-86
14610636
J Pharmacol Exp Ther. 2001 Jul;298(1):1-6
11408518
Neurochem Res. 2004 Sep;29(9):1687-93
15453263
Drug Alcohol Depend. 1993 Jun;33(1):31-9
8370338
Pharmacol Biochem Behav. 1998 Jul;60(3):609-13
9678643
Eur J Pharmacol. 1997 Apr 23;325(1):13-20
9151933
J Pharmacol Exp Ther. 2000 Sep;294(3):1112-9
10945867
Brain Res. 1993 Oct 8;624(1-2):245-52
8252397
Psychopharmacology (Berl). 2003 Aug;169(1):1-9
12811464
Psychopharmacology (Berl). 2001 Sep;157(3):243-53
11605079
Neuropsychopharmacology. 2007 Jul;32(7):1433-51
17164822
Psychopharmacology (Berl). 1997 Feb;129(4):390-7
9085409
Psychopharmacology (Berl). 1995 Dec;122(4):390-94
8657839
J Pharmacol Exp Ther. 2002 Nov;303(2):664-72
12388649
Neuroscience. 2007 Mar 2;145(1):344-9
17207584
Psychopharmacology (Berl). 2002 Feb;160(1):56-66
11862374
Neuroscience. 1997 Dec;81(4):1009-17
9330363
Psychopharmacology (Berl). 2003 Nov;170(3):278-286
12898121
J Pharmacol Exp Ther. 1998 Mar;284(3):1188-96
9495882
Neuropharmacology. 2008 Jun;54(8):1223-32
18452957
Neuropharmacology. 2004;47 Suppl 1:256-73
15464142
Eur J Pharmacol. 1998 Feb 19;343(2-3):119-27
9570458
Psychopharmacology (Berl). 1999 Nov;147(2):135-42
10591880
Nicotine Tob Res. 2004 Jun;6(3):501-7
15203784
Psychopharmacology (Berl). 2005 Apr;179(1):255-61
15619120
Psychopharmacology (Berl). 1989;99(4):473-8
2594913
J Pharmacol Exp Ther. 1991 Jul 1;258(1):178-85
1677037
Endocrinology. 1993 Jul;133(1):11-9
8391419
Psychopharmacology (Berl). 2006 Mar;184(3-4):339-44
16416156
J Neurosci. 2001 Nov 15;21(22):8979-89
11698608
CNS Drug Rev. 2006 Fall-Winter;12(3-4):178-207
17227286
Neuroscience. 2000;96(4):735-42
10727791
Eur J Pharmacol. 2002 Jul 19;448(2-3):185-91
12144940
J Neurochem. 1999 Sep;73(3):1043-50
10461893
Psychopharmacology (Berl). 1993;112(2-3):163-82
7871016
Behav Brain Res. 1995 Feb;67(1):75-80
7748503
Drug Alcohol Depend. 2001 Mar 1;62(1):41-7
11173166
J Neurosci. 1984 Dec;4(12):2906-11
6502210
J Pharmacol Exp Ther. 2004 Jun;309(3):959-69
14982963
Neurochem Res. 1995 Jun;20(6):753-9
7566373
Psychopharmacology (Berl). 1979 Sep;64(3):291-6
41278
Pharmacol Biochem Behav. 1999 Apr;62(4):743-51
10208381
Psychopharmacology (Berl). 1989;98(3):408-11
2501818
Pharmacol Biochem Behav. 2001 Dec;70(4):515-30
11796151
Clin Pharmacol Ther. 1992 Dec;52(6):627-34
1458772
Brain Res. 1994 Aug 8;653(1-2):278-84
7982062
Mol Neurobiol. 1995 Aug-Dec;11(1-3):1-19
8561954
Pharmacol Biochem Behav. 1997 Jul;57(3):441-7
9218268
Psychopharmacology (Berl). 2007 Oct;194(3):395-402
17611741
Neuropharmacology. 2007 Mar;52(3):985-94
17157884
Psychopharmacology (Berl). 2008 Jun;198(3):351-62
18438738
Psychopharmacology (Berl). 2000 Feb;148(3):234-42
10755736
Neuropharmacology. 2003 Sep;45(4):514-23
12907312
Neuropsychopharmacology. 2006 Jun;31(6):1203-11
16192981
Drugs Future. 2004 Dec;29(12):1235-1244
16871320
Nat Rev Drug Discov. 2007 Sep;6(9):746-62
17690709
J Pharmacol Exp Ther. 2002 Aug;302(2):687-95
12130733
Eur J Neurosci. 2006 Dec;24(12):3532-40
17229101